BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17657544)

  • 1. Talc pleurodesis for malignant effusions is preferred over the pleurx catheter (pro position).
    Antevil JL; Putnam JB
    Ann Surg Oncol; 2007 Oct; 14(10):2698-9. PubMed ID: 17657544
    [No Abstract]   [Full Text] [Related]  

  • 2. Talc pleurodesis for malignant pleural effusions is preferred over the pleurx catheter (contrary position).
    Warren W
    Ann Surg Oncol; 2007 Oct; 14(10):2700-1. PubMed ID: 17151792
    [No Abstract]   [Full Text] [Related]  

  • 3. [Talc pleurodesis in recurrent malignant pleural effusion--a prospective follow-up study].
    Walter M; Türler A; Schmitz-Rixen T
    Zentralbl Chir; 1996; 121(3):216-22. PubMed ID: 8867348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: a randomised trial.
    Goodman A; Davies CW
    Lung Cancer; 2006 Oct; 54(1):51-5. PubMed ID: 16920219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant pleural effusions: treatment with small-bore-catheter thoracostomy and talc pleurodesis.
    Marom EM; Patz EF; Erasmus JJ; McAdams HP; Goodman PC; Herndon JE
    Radiology; 1999 Jan; 210(1):277-81. PubMed ID: 9885620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and safety in the treatment of pleural effusions with the PleurX catheter: a retrospective analysis].
    Blaukovitsch M; Strassburg A; Müller E; Zabel P; Hauber HP
    Pneumologie; 2011 Sep; 65(9):558-64. PubMed ID: 21512973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
    Stefani A; Natali P; Casali C; Morandi U
    Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of malignant pleural effusions by talc pleurodesis.
    Waqainabete I
    Pac Health Dialog; 2006 Sep; 13(2):103-5. PubMed ID: 18181397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Talc pleurodesis for treating malignant pleural effusions.
    Rodriguez-Panadero F
    Chest; 1995 Oct; 108(4):1178-9. PubMed ID: 7555141
    [No Abstract]   [Full Text] [Related]  

  • 10. [Talc--a standard drug in the treatment of malignant pleural effusion].
    Bednár M; Bezdícek P
    Cas Lek Cesk; 1999 Jan; 138(3):82-4. PubMed ID: 10376391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.
    Yildirim H; Metintas M; Ak G; Metintas S; Erginel S
    Lung Cancer; 2008 Oct; 62(1):139-44. PubMed ID: 18403045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the best treatment for malignant pleural effusions?
    Zahid I; Routledge T; Billè A; Scarci M
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):818-23. PubMed ID: 21325469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient Talc Administration by Indwelling Pleural Catheter for Malignant Effusion.
    Bhatnagar R; Keenan EK; Morley AJ; Kahan BC; Stanton AE; Haris M; Harrison RN; Mustafa RA; Bishop LJ; Ahmed L; West A; Holme J; Evison M; Munavvar M; Sivasothy P; Herre J; Cooper D; Roberts M; Guhan A; Hooper C; Walters J; Saba TS; Chakrabarti B; Gunatilake S; Psallidas I; Walker SP; Bibby AC; Smith S; Stadon LJ; Zahan-Evans NJ; Lee YCG; Harvey JE; Rahman NM; Miller RF; Maskell NA
    N Engl J Med; 2018 Apr; 378(14):1313-1322. PubMed ID: 29617585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study.
    Korsic M; Badovinac S; Cucevic B; Janevski Z
    Wien Klin Wochenschr; 2015 Dec; 127(23-24):963-9. PubMed ID: 25860847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term indwelling pleural catheter (PleurX) for malignant pleural effusion unsuitable for talc pleurodesis.
    Sioris T; Sihvo E; Salo J; Räsänen J; Knuuttila A
    Eur J Surg Oncol; 2009 May; 35(5):546-51. PubMed ID: 18644696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Talc pleurodesis in malignant pleural effusions].
    Kolschmann S; Ballin A; Juergens UR; Rohde G; Gessner C; Hammerschmidt S; Wirtz H; Gillissen A
    Pneumologie; 2006 Feb; 60(2):89-95. PubMed ID: 16463249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on talc, bleomycin, and the tetracyclines in the treatment of malignant pleural effusions.
    Schafers SJ; Dresler CM
    Pharmacotherapy; 1995; 15(2):228-35. PubMed ID: 7542766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of malignant pleural effusions and talc pleurodesis.
    Antony VB
    Pneumologie; 1999 Oct; 53(10):493-8. PubMed ID: 10596552
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of comparison of efficacy and safety of talc and povidone iodine for pleurodesis of malignant pleural effusions.
    Das SK; Saha SK; Das A; Halder AK; Banerjee SN; Chakraborty M
    J Indian Med Assoc; 2008 Sep; 106(9):589-90, 592. PubMed ID: 19552086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of malignant pleural effusions.
    Lee YC; Light RW
    Respirology; 2004 Jun; 9(2):148-56. PubMed ID: 15182263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.